Compositions comprising dimocarpus extract for use in the treatment or prevention of an infection caused by an enveloped virus
OwnerPrayudh MAHAGITSIRI, Chalermchai MAHAGITSIRI +4inventors
InventorsPrayudh MAHAGITSIRI, Chalermchai MAHAGITSIRI, Ausana MAHAGITSIRI, Thomas JAKSCHITZ, Gökhan SENLI, Günther BONN
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition comprising or corresponding to an extract obtained from Dimocarpus longan for use in the treatment and/or prevention of a disease caused by an enveloped virus, in particular caused by coronaviruses such as SARS-CoV, MERS-CoV and SARS-CoV-2 or influenza viruses such as influenza A and influenza B and/or at least one symptom thereof.
Claims23
A method comprising administering a composition comprising Dimocarpus extract to a subject that has a respiratory infection with an enveloped virus, enveloped single stranded virus, enveloped positive single strand RNA virus (+ssRNA) virus, an influenza or a coronavirus.
2-3. (canceled)
A composition comprising Dimocarpus extract, wherein the Dimocarpus extract comprises vitamin C, one or more polyphenols selected from corilagin, gallic acid, ellagic acid, ellagic acid conjugates, (−)-epicatechin, quercetin, kaempferol, tannic acid (tannin) and chlorogenic acid;
- protocatechuic acid, brevifolin, γ-aminobutyric acid (GABA), carbohydrates and water.
Dependencies are inferred from the claim text.